0.6246
price up icon4.97%   0.0296
after-market Dopo l'orario di chiusura: .62 -0.0046 -0.74%
loading
Precedente Chiudi:
$0.595
Aprire:
$0.59
Volume 24 ore:
619.66K
Relative Volume:
0.08
Capitalizzazione di mercato:
$37.16M
Reddito:
$950.10K
Utile/perdita netta:
$-16.69M
Rapporto P/E:
-0.7525
EPS:
-0.83
Flusso di cassa netto:
$-15.16M
1 W Prestazione:
+8.40%
1M Prestazione:
-29.02%
6M Prestazione:
-32.79%
1 anno Prestazione:
-43.22%
Intervallo 1D:
Value
$0.5851
$0.6366
Intervallo di 1 settimana:
Value
$0.576
$0.6566
Portata 52W:
Value
$0.3067
$1.80

Femasys Inc Stock (FEMY) Company Profile

Name
Nome
Femasys Inc
Name
Telefono
770-500-3910
Name
Indirizzo
3950 JOHNS CREEK COURT, SUWANEE
Name
Dipendente
71
Name
Cinguettio
Name
Prossima data di guadagno
2025-08-08
Name
Ultimi documenti SEC
Name
FEMY's Discussions on Twitter

Confronta FEMY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Instruments & Supplies icon
FEMY
Femasys Inc
0.6246 35.40M 950.10K -16.69M -15.16M -0.83
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
592.27 210.16B 9.61B 2.77B 2.27B 7.555
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
202.71 58.51B 21.84B 1.68B 2.67B 5.8293
Medical Instruments & Supplies icon
ALC
Alcon Inc
81.02 40.19B 10.19B 1.05B 1.38B 2.1044
Medical Instruments & Supplies icon
RMD
Resmed Inc
248.21 36.37B 5.26B 1.44B 1.76B 9.7713
Medical Instruments & Supplies icon
MDLN
Medline Inc
40.43 31.30B 27.43B 1.27B 1.01B 1.5829

Femasys Inc Stock (FEMY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-11-20 Iniziato Laidlaw Buy

Femasys Inc Borsa (FEMY) Ultime notizie

pulisher
01:47 AM

How Femasys Inc. stock reacts to inflationary pressures2026 world cup usa national team group stage goalkeepers counter attacking expert forecast guide - ulpravda.ru

01:47 AM
pulisher
Jan 04, 2026

Earnings Beat: Will MARZ stock keep high P E multiples2025 Biggest Moves & Pattern Based Trade Signal System - moha.gov.vn

Jan 04, 2026
pulisher
Jan 02, 2026

Femasys gains UK approval for women's health products - MSN

Jan 02, 2026
pulisher
Dec 30, 2025

Market Leaders: How strong is Femasys Inc stock balance sheetQuarterly Earnings Summary & AI Forecast for Swing Trade Picks - moha.gov.vn

Dec 30, 2025
pulisher
Dec 29, 2025

User | theeveningleader.comFemasys Inc.Common Stock (Nasdaq:FEMY) Stock Quote - FinancialContent

Dec 29, 2025
pulisher
Dec 24, 2025

Femasys files for at-the-market offering of up to $9.8 million in common stock - Investing.com India

Dec 24, 2025
pulisher
Dec 23, 2025

Femasys Launches At-the-Market Common Stock Offering - TipRanks

Dec 23, 2025
pulisher
Dec 23, 2025

Femasys files for at-the-market offering of up to $9.8 million in common stock By Investing.com - Investing.com South Africa

Dec 23, 2025
pulisher
Dec 23, 2025

Femasys Inc Files Prospectus for Stock Offering - TradingView — Track All Markets

Dec 23, 2025
pulisher
Dec 22, 2025

Suwanee company Femasys Inc. gets FDA approval for diagnostic device - The Business Journals

Dec 22, 2025
pulisher
Dec 21, 2025

Will Femasys Inc. stock maintain growth story2025 Market Sentiment & Target Return Focused Stock Picks - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

Contemporary OB/GYN week in review: FemVue clearance, flibanserin approval, and more - Contemporary OB/GYN

Dec 20, 2025
pulisher
Dec 20, 2025

Swing Trade: Why Femasys Inc. stock is a must watch in 20252025 Geopolitical Influence & Accurate Intraday Trading Signals - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

What momentum indicators show for Femasys Inc. stockMarket Sentiment Review & Risk Managed Trade Strategies - Bölüm Sonu Canavarı

Dec 20, 2025
pulisher
Dec 20, 2025

Why Femasys Inc. stock is rated strong buyJuly 2025 Momentum & Real-Time Volume Spike Alerts - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Femasys receives FDA clearance for FemVue Controlled diagnostic device By Investing.com - Investing.com Australia

Dec 19, 2025
pulisher
Dec 19, 2025

How interest rate cuts could boost Femasys Inc. stockMarket Growth Review & Technical Entry and Exit Tips - Bölüm Sonu Canavarı

Dec 19, 2025
pulisher
Dec 19, 2025

How strong is Femasys Inc. stock balance sheet2025 Trading Recap & Consistent Profit Focused Trading Strategies - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Why Femasys Inc. stock is a must watch in 20252025 Market Sentiment & Growth Oriented Trade Recommendations - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

What analyst consensus says on Femasys Inc. stockJuly 2025 Action & AI Powered Market Trend Analysis - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Femasys Earnings Notes - Trefis

Dec 19, 2025
pulisher
Dec 18, 2025

PharmaCyte Biotech (Nasdaq: PMCB) reports Q2 loss and details QCLS, Femasys deals - Stock Titan

Dec 18, 2025
pulisher
Dec 18, 2025

Femasys Inc. Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device - marketscreener.com

Dec 18, 2025
pulisher
Dec 18, 2025

FDA clears FemVue Controlled for in-office tubal assessment - Contemporary OB/GYN

Dec 18, 2025
pulisher
Dec 18, 2025

Femasys secures U.S. FDA clearance for next-generation Femvue diagnostic device - marketscreener.com

Dec 18, 2025
pulisher
Dec 18, 2025

Femasys Gains FDA Clearance for FemVue Diagnostic Device - TipRanks

Dec 18, 2025
pulisher
Dec 18, 2025

Femasys gains FDA clearance for FemVue diagnostic device - MSN

Dec 18, 2025
pulisher
Dec 18, 2025

Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device - The Manila Times

Dec 18, 2025
pulisher
Dec 18, 2025

Femasys Inc Secures FDA Clearance for FemVue Diagnostic Device - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Femasys (NASDAQ: FEMY) secures FDA clearance for next-generation FemVue diagnostic - Stock Titan

Dec 18, 2025
pulisher
Dec 18, 2025

Femasys receives FDA clearance for FemVue Controlled diagnostic device - Investing.com

Dec 18, 2025
pulisher
Dec 18, 2025

Femasys Inc. Receives FDA Clearance for Innovative FemVue Controlled Device to Enhance Fallopian Tube Evaluation and Workflow Efficiency - Quiver Quantitative

Dec 18, 2025
pulisher
Dec 18, 2025

New device could make fallopian tube testing simpler for fertility care - Stock Titan

Dec 18, 2025
pulisher
Dec 14, 2025

PMCB Stock Jumps 25% After Company Sells Stake In Femasys - MSN

Dec 14, 2025
pulisher
Dec 12, 2025

Femasys Secures Major Order for FemBloc Launch - MSN

Dec 12, 2025
pulisher
Dec 12, 2025

Femasys Receives FDA Approval for FemBloc Trial - MSN

Dec 12, 2025
pulisher
Dec 08, 2025

FDA Approves Final Trial Phase for Femasys’ Permanent Birth Control Product - Medical Product Outsourcing

Dec 08, 2025
pulisher
Dec 05, 2025

PharmaCyte’s Successful Stake Earns them Millions - StocksToTrade

Dec 05, 2025
pulisher
Dec 05, 2025

PharmaCyte Boosts Financial Position with Femasys Stake Sale - timothysykes.com

Dec 05, 2025
pulisher
Dec 01, 2025

Femasys Inc Stock Analysis and ForecastTechnical Breakout Signals & Minimal Capital Trading - earlytimes.in

Dec 01, 2025
pulisher
Nov 30, 2025

CapEx per share of Femasys Inc. – NASDAQ:FEMY - TradingView

Nov 30, 2025
pulisher
Nov 29, 2025

Femasys (NASDAQ:FEMY) Rating Increased to Hold at Wall Street Zen - MarketBeat

Nov 29, 2025
pulisher
Nov 27, 2025

PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN

Nov 27, 2025
pulisher
Nov 27, 2025

Energy Moves: Why Femasys Inc. stock is a must watch in 2025Weekly Investment Report & Community Verified Trade Alerts - moha.gov.vn

Nov 27, 2025
pulisher
Nov 25, 2025

PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million - Investing.com Nigeria

Nov 25, 2025
pulisher
Nov 25, 2025

PharmaCyte Biotech stock soars after successful Femasys stake sale By Investing.com - Investing.com Australia

Nov 25, 2025

Femasys Inc Azioni (FEMY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$166.81
price down icon 0.51%
$84.24
price up icon 1.30%
medical_instruments_supplies COO
$83.90
price down icon 0.50%
$74.96
price up icon 0.07%
medical_instruments_supplies WST
$278.44
price down icon 0.85%
$40.43
price up icon 1.66%
Capitalizzazione:     |  Volume (24 ore):